Head and Neck Cancer

Head and Neck Cancer Survivors With Dysphagia Prone to Anxiety, Depression

By

Jennifer Larson

Publish Date January 5, 2022

Study reveals a key indicator for the need to assess head and neck cancer survivors for risk of anxiety and depression.

Increased Uptake of HPV Vaccine Projected to Reduce Oropharyngeal Cancer Incidence Over 25 Years

By

Vicki Moore, PhD

Publish Date November 9, 2021

A new study projects that increasing HPV vaccination rates will trend toward reduced incidence of oropharyngeal cancer among younger adults until 2045.

Expert Panel Advises Against Aloe Vera for Treating Radiation Dermatitis

By

Bryant Furlow

Publish Date October 19, 2021

The panel, convened by the International Society of Nurses in Cancer Care, developed evidence-based guidelines for managing radiation dermatitis in patients undergoing radiotherapy.

Perspectives on Tobacco Cessation Among Patients With HNC, Clinicians

By

Jessica Nye, PhD

Publish Date September 22, 2021

In-depth qualitative interviews with oncology clinicians and current and former smokers reveal some common perspectives on smoking and cessation.

2008 to 2017 Saw Drop in Malignant Brain Tumor Incidence

Publish Date August 31, 2021

Incidence among children, adolescents increased 0.5 to 0.7 percent; malignant tumor incidence highest for males, non-Hispanic Whites

Multifocality Appears to Increase Risk of Recurrence in Papillary Thyroid Carcinoma

By

Leah Lawrence

Publish Date August 31, 2021

The risk of recurrence varied by patient age, tumor size, and number of foci.

Gemcitabine Plus Cisplatin Improves Overall Survival in Advanced Nasopharyngeal Carcinoma

By

Sucharita Mistry, PhD

Publish Date August 20, 2021

Gemcitabine plus cisplatin reduced the risk of death by 28%.

Sodium Thiosulfate Appears to Decrease Ototoxic Effects of Platinum Chemo Without Compromising Efficacy

By

Leah Lawrence

Publish Date August 12, 2021

More studies are needed to confirm if there is an effect on survival, according to researchers.

Personalized Radiotherapy Shields May Effectively Protect Healthy Tissue During RT for Prostate, Oral Cancer

By

Bryant Furlow

Publish Date August 6, 2021

Early results demonstrate the potential of personalized 3D-printed shields for protecting healthy GI tissue in patients undergoing radiotherapy for prostate cancer.

Response Endpoints Deemed ‘Poor Surrogates’ for Overall Survival in Trials of Immune Checkpoint Inhibitors

By

Jonathan Goodman, MPhil

Publish Date August 5, 2021

Response endpoints were not strongly correlated with overall survival at the trial level.